Research
Research into pancreatic cancer has been underfunded for decades – it only receives 3% of the UK cancer research budget. This is three times less than research spend on breast cancer.
www.pancreaticcancer.org.ukHere’s a concise update on the latest news from Pancreatic Cancer UK.
Key developments
- NHS expansion of early detection efforts: A recent NHS England initiative aims to identify people at higher risk of pancreatic cancer (e.g., older adults with risk indicators) and offer urgent tests, reflecting a push to diagnose earlier and improve survival. This program builds on existing partnerships with Pancreatic Cancer UK and aligns with national priorities to tackle one of the deadliest cancers in the UK.[9]
- National Cancer Plan (England) context: Pancreatic Cancer UK and related groups highlighted responses to a new ten-year National Cancer Plan for England announced around World Cancer Day in 2026, signaling sustained government focus on cancer care and early detection that could impact pancreatic cancer services and research funding.[3]
- Pancreatic Cancer UK activity and impact: The charity reports ongoing work to improve care quality, advocate for policies (e.g., optimal care pathways), address shortages (like pancreatic enzyme replacement therapy, PERT), and mobilize supporters to influence MPs and stakeholders, with substantial fundraising and public engagement to fuel research and patient support.[4][5]
- Research and media presence: Pancreatic Cancer UK continues to publish updates on research progress, patient support, and policy responses via their media centre and impact pages, underscoring a focus on translating research into patient benefit.[5][4]
What this means for patients and families
- Earlier detection efforts could lead to more people being diagnosed at a treatable stage, potentially improving outcomes.[9]
- National cancer policy developments may improve cancer care infrastructure, access to treatments, and support services across the UK, with Pancreatic Cancer UK actively advocating for these changes.[3][4]
- Ongoing research and patient support channels remain available through Pancreatic Cancer UK, including dedicated information, helplines, and updates on breakthroughs and clinical trials.[7][8]
If you’d like, I can pull more detailed summaries from specific Pancreatic Cancer UK pages (e.g., their latest media centre releases or specific policy responses) and provide a short, sourced briefing. I can also monitor for upcoming updates and note any new NHS pilot results or policy changes.